About

Bringing scientific and technical judgement together with the realities of the Türkiye market.

Arda Can Aydın is preparing an independent corporate structure that critically assesses scientific, laboratory and industrial technologies and seeks to develop appropriate local partnership pathways.

Why This Structure?

Science, market and responsibility at the same table.

New technologies need more than a compelling scientific story. Evidence quality, genuine need, stakeholder structures in Türkiye, regulatory boundaries and the right business model must be assessed together.

This approach is built on an independent assessment discipline that questions scientific and commercial fit rather than automatically endorsing every technology.

01

Evidence-led

Every material claim is linked to a source, experience or transparent process.

02

Independent

An area of interest is not presented as a representation right or formal approval.

03

Clear responsibility

The scope of each engagement and the tasks outside it are defined from the outset.

04

Specific to Türkiye

Global technology narratives are tested against local stakeholders and market realities.

ACA

Founder Profile

Arda Can Aydın

He is a biologist and pharmacology researcher with experience in experimental neuroscience, Alzheimer’s disease models and translating scientific findings into practice. His peer-reviewed work includes research on cannabidiol and cannabigerol in an experimental Alzheimer’s disease model and a review of Alzheimer’s disease and dementia.

He is currently preparing an independent corporate structure that combines this scientific foundation with market and business-development experience in Türkiye.

Review verified evidence